Your browser doesn't support javascript.
loading
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma.
Liu, Enze; Sudha, Parvathi; Becker, Nathan; Jaouadi, Oumaima; Suvannasankha, Attaya; Lee, Kelvin; Abonour, Rafat; Abu Zaid, Mohammad; Walker, Brian A.
Afiliação
  • Liu E; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Sudha P; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Becker N; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Jaouadi O; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Suvannasankha A; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Lee K; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Abonour R; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Abu Zaid M; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.
  • Walker BA; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA. bw75@iu.edu.
Blood Cancer J ; 13(1): 144, 2023 09 11.
Article em En | MEDLINE | ID: mdl-37696786

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos